Alvarez & Marsal brings a differentiated transformation offering to corporations, leveraging the functional expertise offered by performance improvement talent coupled with the firm’s renowned restructuring and private equity capabilities. As businesses are vulnerable or looking to keep pace with constant disruptors, A&M is ideally positioned to bring the experience and skills needed to address activist investors and position corporations for success through enterprise-wide change.
With more than three decades of executive leadership and Board service experience, Mr. Berardino has a proven track record managing complex Board and C-Suite dynamics to enact change.
Previously, Mr. Berardino was an audit partner with Arthur Andersen where he spent more than 30 years in various client-serving and leadership roles, including CEO of Andersen Worldwide.
Mr. Berardino has lectured extensively on corporate governance, leadership and ethics before senior corporate executives and college campuses. He served in various capacities, from CEO to Chairman of the Board for Profectus Bio Sciences.
He is currently a member of the Board of Advisors for the University of Maryland School of Medicine’s Institute of Human Virology and has served on several public company Boards of Directors.
Mr. Berardino earned a bachelor's degree from Fairfield University, where he served as a member of the Board of Trustees for 18 years, and has chaired the Advancement and Finance Committees.